Targeting Mechanosensitive Transcription Factors in Atherosclerosis

Trends Pharmacol Sci. 2019 Apr;40(4):253-266. doi: 10.1016/j.tips.2019.02.004. Epub 2019 Feb 28.

Abstract

Atherosclerosis is the primary underlying cause of cardiovascular disease which preferentially develops at arterial regions exposed to disturbed flow (DF), but much less at regions of unidirectional laminar flow (UF). Recent studies have demonstrated that DF and UF differentially regulate important aspects of endothelial function, such as vascular inflammation, oxidative stress, vascular tone, cell proliferation, senescence, mitochondrial function, and glucose metabolism. DF and UF regulate vascular pathophysiology via differential regulation of mechanosensitive transcription factors (MSTFs) (KLF2, KLF4, NRF2, YAP/TAZ/TEAD, HIF-1α, NF-κB, AP-1, and others). Emerging studies show that MSTFs represent promising therapeutic targets for the prevention and treatment of atherosclerosis. We present here a comprehensive overview of the role of MSTFs in atherosclerosis, and highlight future directions for developing novel therapeutic agents by targeting MSTFs.

Keywords: atherosclerosis; disturbed flow; endothelial cells; shear stress; transcription factors; unidirectional laminar flow.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / physiopathology
  • Drug Development / methods
  • Humans
  • Kruppel-Like Factor 4
  • Mechanotransduction, Cellular / physiology
  • Molecular Targeted Therapy*
  • Transcription Factors / metabolism*

Substances

  • KLF4 protein, human
  • Kruppel-Like Factor 4
  • Transcription Factors